SLC5A2 and endothelial dysfunction: Since SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated beneficial effects on both endothelial dysfunction and inflammation, their utilization in MINOCA patients seems promising and warrants further investigation in specifically designed studies.